Life Sciences
5.6
Malaria vaccine RTS,S/AS01 confirmed safe and effective in major review
A Lancet Infectious Diseases analysis validates the safety and efficacy of RTS,S/AS01, the first malaria vaccine approved for widespread use. The finding matters: it could accelerate adoption in endemic regions and influence procurement decisions by health agencies and governments facing one of the world's deadliest infectious diseases.
Originaltitel: RTS,S/AS01 malaria vaccine-proven safe and effective?